MILLENNIUM MANAGEMENT LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,135,076
+3.3%
48,857
+63.3%
0.00%
+33.3%
Q2 2023$6,909,210
+20583.2%
29,910
-78.3%
0.00%
-84.2%
Q1 2023$33,405
+43.7%
137,887
+72.1%
0.02%
+46.2%
Q4 2022$23,249
-97.6%
80,100
+429.1%
0.01%
Q3 2022$984,000
+213.4%
15,138
+245.5%
0.00%
Q2 2022$314,000
-76.5%
4,381
-72.2%
0.00%
-100.0%
Q4 2021$1,337,000
-30.2%
15,782
-34.3%
0.00%0.0%
Q3 2021$1,916,000
-57.1%
24,019
-47.7%
0.00%
-66.7%
Q2 2021$4,469,000
+497.5%
45,883
+617.0%
0.00%
+200.0%
Q1 2021$748,000
+42.2%
6,399
+44.3%
0.00%0.0%
Q3 2020$526,000
-88.6%
4,434
-89.1%
0.00%
-83.3%
Q2 2020$4,618,000
+36.3%
40,775
-19.7%
0.01%
-25.0%
Q1 2020$3,388,000
+107.3%
50,747
+167.7%
0.01%
+166.7%
Q3 2019$1,634,000
+27.5%
18,960
+55.0%
0.00%
+50.0%
Q2 2019$1,282,000
+100.3%
12,231
+139.3%
0.00%
+100.0%
Q1 2019$640,000
-85.0%
5,111
-86.5%
0.00%
-83.3%
Q4 2018$4,258,000
+59.1%
37,778
+202.2%
0.01%
+100.0%
Q3 2018$2,677,000
-79.4%
12,500
-73.1%
0.00%
-82.4%
Q2 2018$13,007,000
+20.7%
46,505
-49.6%
0.02%
+21.4%
Q1 2018$10,779,000
+2910.9%
92,291
+2263.4%
0.01%
Q4 2017$358,000
-26.3%
3,905
-87.6%
0.00%
-100.0%
Q1 2017$486,000
+137.1%
31,571
+94.9%
0.00%
Q3 2016$205,00016,2020.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders